Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.Published in:Transfusion, 2005, v. 45, n. 9, p. 1481, doi. 10.1111/j.1537-2995.2005.00560.xBy:Millward, P. M.;Bandarenko, N.;Chang, P. P.;Stagg, K. F.;Afenyi-Annan, A.;Hay, S. N.;Brecher, M. E.Publication type:Article